Search

Your search keyword '"Cavaletti, G."' showing total 2,154 results

Search Constraints

Start Over You searched for: Author "Cavaletti, G." Remove constraint Author: "Cavaletti, G."
2,154 results on '"Cavaletti, G."'

Search Results

1. Do patients’ and referral centers’ characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register

2. Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants

3. A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata

4. Electrodiagnostic subtyping in Guillain–Barré syndrome patients in the International Guillain–Barré Outcome Study

5. Mobile Applications to Support Multiple Sclerosis Communities: The Post-COVID-19 Scenario

6. CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON?

8. Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat

9. Repurposing chemotherapy-induced peripheral neuropathy grading

10. Vincristine Disposition and Neurotoxicity Are Unchanged in Humanized CYP3A5 Mice

11. Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation

13. Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection

14. NEUROINFLAMMATION AS A POTENTIAL TARGET FOR CIPN DIAGNOSTIC AND TREATMENT

16. Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization

18. Proteasome inhibitors-based chemotherapy induced neurotoxicity: focus on cytoskeleton and mitochondrial dysfunction

19. Oxaliplatin-induced peripheral neurotoxicity: molecular insights

22. Role of Mouse Organic Cation Transporter 2 for Nephro- and Peripheral Neurotoxicity Induced by Chemotherapeutic Treatment with Cisplatin

23. Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy

24. Current use of fluid biomarkers as outcome measures in Multiple Sclerosis (MS): a review of ongoing pharmacological clinical trials

25. Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry

26. CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome

27. Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register

28. Studies to Assess the Utility of Serum Neurofilament Light Chain as a Biomarker in Chemotherapy-Induced Peripheral Neuropathy

29. Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy

31. Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent

32. Multimodal Comparison of Diabetic Neuropathy in Aged Streptozotocin-Treated Sprague–Dawley and Zucker Diabetic Fatty Rats

33. Engineered mesoporous silica-based nanoparticles as smart chemotherapy nanodevice for bortezomib administration

34. Self-Reported Assessment of the Socio-Economic Impact of Anticancer Chemotherapy-Related Neurotoxicity

35. EXPLOITING HDAC6 SPECIFIC INHIBITORS TO REDUCE OHP-INDUCED NEUROTOXICITY

38. Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)

41. Acute and chronic Oxaliplatin-induced peripheral neurotoxicity: two sides of the same coin

42. Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP

43. Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values

44. Clinical and preclinical features of eribulin-related peripheral neuropathy

45. The neurophysiological lesson from the Italian CIDP database

46. Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients with Primary Progressive Multiple Sclerosis

47. Ubiquitin Proteasome System and Microtubules Are Master Regulators of Central and Peripheral Nervous System Axon Degeneration

48. Rigosertib and cholangiocarcinoma: A cell cycle affair

49. Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database

50. Exercise and Neuropathy: Systematic Review with Meta-Analysis

Catalog

Books, media, physical & digital resources